Clinical Trials Browser

Recurrence, Triple Negative Breast Neoplasms

NCT04395989 2023-12-22

FUTURE-SUPER

Phase 2 Unknown

139 enrolled

Breast

Triple Negative Breast Neoplasms

NCT03961698 2023-08-14

MARIO-3

Phase 2 Unknown

91 enrolled

BreastGenitourinary

Breast Neoplasms, Carcinoma, Renal Cell, Triple Negative Breast Neoplasms

NCT05792410 2023-03-31

A Phase Ⅰb/Ⅱ Clinical Study of SHR-A1811 Combined With Other Therapies in Patients With HER2 Low Advanced or Metastatic Breast Cancer.

Phase 1/2 Unknown

300 enrolled

Breast

Breast Neoplasms

NCT05357417 2022-09-16

Utidelone Plus Bevacizumab for Advanced Breast Cancer With Brain Metastases

Phase 2 Unknown

100 enrolled

Breast

Breast Neoplasms

NCT05303038 2022-06-09

Castle06(BC)

Phase 2 Unknown

15 enrolled

Breast

Triple Negative Breast Neoplasms

NCT04389073 2022-02-25

Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine

Phase 2 Unknown

138 enrolled

Breast

Breast Neoplasms

NCT02185352 2021-05-07

A-Plus

Phase 2 Unknown

120 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT03925233 2019-04-24

Breast Cancer Treatment Based on Organ-like Culture

Unknown

300 enrolled

Breast

Breast Cancer Organoids

NCT00408408 2017-09-18

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

Phase 3 Unknown

1,206 enrolled 19 charts

Breast

Breast Neoplasms

NCT00957125 2016-09-08

PROMIX

Phase 2 Unknown

151 enrolled

Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT02829008 2016-07-12

Low -Dose-bevacizumab and Pemetrexed Versus TPC in Metastatic HER2-negative Breast Cancer Patients

Phase 2 Unknown

120 enrolled

Breast

Breast Neoplasms

NCT02175446 2016-06-15

GIM11-BERGI

Phase 2 Unknown

61 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00436709 2014-01-06

Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer

Phase NA Unknown

75 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00404404 2013-12-18

ABI-007 and Bevacizumab in Treating Women With Recurrent or Metastatic Breast Cancer

Phase 2 Unknown

35 enrolled

Breast

Breast Neoplasms

NCT00262067 2013-12-13

A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)

Phase 3 Unknown

1,237 enrolled 14 charts

Breast

Breast Neoplasms

NCT01880385 2013-06-19

Beva

Phase 1 Unknown

30 enrolled

Breast

Inflammatory Breast Neoplasms

NCT00777673 2013-01-04

Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.

Phase 2 Unknown

60 enrolled

Breast

Breast Neoplasms

NCT01652560 2012-07-30

BIBC

Unknown

50 enrolled

Breast

Breast Neoplasms

NCT01641406 2012-07-16

NACprotocol

Phase 2 Unknown

60 enrolled

Breast

Breast Carcinoma In Situ, Carcinoma, Lobular, Inflammatory Breast Neoplasms

NCT01321775 2011-03-24

Bevacizumab and Trastuzumab With Weekly Paclitaxel Followed, After Surgery, by Encapsuled Liposomal Doxorubicin, Cyclophosphamide and Trastuzumab as Adjuvant Treatment After Surgery on Women With Her2+ Breast Cancer

Phase 2 Unknown

44 enrolled

Breast

Breast Neoplasms

NCT01195298 2010-09-06

Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast Cancer

Phase 2 Unknown

88 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01093235 2010-03-25

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

Phase 3 Unknown

800 enrolled

Breast

Breast Neoplasms, Postoperative Complications, Breast Neoplasms, Male, Inflammatory Breast Neoplasms, Cardiotoxicity

NCT00318513 2006-05-10

Safety Study of Bevacizumab to Treat Women With a History of Breast Cancer and Suffering From Upper Extremity Lymphedema

Phase 1 Unknown

35 enrolled

Breast

Breast Neoplasms, Lymphedema

Clinical Trials

BELLA

FUTURE-SUPER

MARIO-3

A Phase Ⅰb/Ⅱ Clinical Study of SHR-A1811 Combined With Other Therapies in Patients With HER2 Low Advanced or Metastatic Breast Cancer.

Utidelone Plus Bevacizumab for Advanced Breast Cancer With Brain Metastases

Castle06(BC)

Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine

A-Plus

Breast Cancer Treatment Based on Organ-like Culture

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

PROMIX

Low -Dose-bevacizumab and Pemetrexed Versus TPC in Metastatic HER2-negative Breast Cancer Patients

GIM11-BERGI

Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer

ABI-007 and Bevacizumab in Treating Women With Recurrent or Metastatic Breast Cancer

A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)

Beva

Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.

BIBC

NACprotocol

Bevacizumab and Trastuzumab With Weekly Paclitaxel Followed, After Surgery, by Encapsuled Liposomal Doxorubicin, Cyclophosphamide and Trastuzumab as Adjuvant Treatment After Surgery on Women With Her2+ Breast Cancer

Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast Cancer

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

Safety Study of Bevacizumab to Treat Women With a History of Breast Cancer and Suffering From Upper Extremity Lymphedema